Dow Up 0.76% Nasdaq Up 0.69%

More On GLAXF

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

GlaxoSmithKline plc (GLAXF)

-Other OTC
22.67 Down 0.39(1.69%) Oct 24, 3:58PM EDT
Prev Close:23.06
Open:23.17
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:22.59 - 23.17
52wk Range:21.22 - 28.56
Volume:7,957
Avg Vol (3m):5,649
Market Cap:108.91B
P/E (ttm):14.52
EPS (ttm):1.56
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):0.24
P/S (ttm):2.80
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :93.44
Quarterly EPS Est (Dec-14) :28.33
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):7.00

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, such as vaccines, over-the-counter medicines, and health-related consumer products worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback